Efficacy study of carboplastin/TS-1 during postoperative adjuvant chemotherapy after complete resection of non-small cell lung cancer at pathological stage II and IIIA in elderly patients older than 75 years old

Trial Profile

Efficacy study of carboplastin/TS-1 during postoperative adjuvant chemotherapy after complete resection of non-small cell lung cancer at pathological stage II and IIIA in elderly patients older than 75 years old

Recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Nov 2015

At a glance

  • Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms Escargo002; Escargot 002
  • Most Recent Events

    • 16 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top